These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3740531)

  • 1. Malignant hyperthermia: removal of volatile anesthetic agents from the breathing circuit using activated charcoal.
    Greene ER
    Anesthesiology; 1986 Aug; 65(2):240-1. PubMed ID: 3740531
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated charcoal adsorption of volatile anesthetic agents for anesthesia machine preparation of malignant hyperthermia susceptible patients.
    Martin JW; Welliver MD
    AANA J; 2013 Jun; 81(3):169-71. PubMed ID: 23923663
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant hyperthermia and charcoal absorbent: too hot to handle.
    Block FE
    Anesth Analg; 2011 Jun; 112(6):1270-1. PubMed ID: 21613194
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.
    Birgenheier N; Stoker R; Westenskow D; Orr J
    Anesth Analg; 2011 Jun; 112(6):1363-70. PubMed ID: 21543783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia].
    Jantzen JP; Eck J; Kleemann PP
    Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory surgery and malignant hyperthermia.
    Brandom BW
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):744-7. PubMed ID: 19812484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Malignant Hyperthermia Association of the United States-Recommended Methods of Preparation for Malignant Hyperthermia-Susceptible Patients Using Dräger Zeus Anesthesia Workstations and Associated Costs.
    Neira VM; Al Madhoun W; Ghaffari K; Barrowman N; Berrigan P; Splinter W
    Anesth Analg; 2019 Jul; 129(1):74-83. PubMed ID: 29847377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of three different types of management on the elimination kinetics of volatile anaesthetics. Implications for malignant hyperthermia treatment.
    Reber A; Schumacher P; Urwyler A
    Anaesthesia; 1993 Oct; 48(10):862-5. PubMed ID: 8238827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
    Gunter JB; Ball J; Than-Win S
    Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a formal statistical analysis always necessary?
    Woehlck H
    Anesth Analg; 2011 Jun; 112(6):1268-9. PubMed ID: 21613193
    [No Abstract]   [Full Text] [Related]  

  • 11. Malignant hyperthermia, a surgeon's nightmare.
    Lowe MK
    J Foot Surg; 1985; 24(2):139-41. PubMed ID: 2985684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cognitive aid checklist leading to successful treatment of malignant hyperthermia in an infant undergoing cranioplasty.
    Ranganathan P; Phillips JH; Attaallah AF; Vallejo MC
    Anesth Analg; 2014 Jun; 118(6):1387. PubMed ID: 24842184
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of charcoal filters in malignant hyperthermia: have they found their place?
    Bilmen JG; Hopkins PM
    Anaesthesia; 2019 Jan; 74(1):13-16. PubMed ID: 30088269
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of intraoperative malignant hyperthermia during renal transplantation.
    Goss JA; Brennan DC; Miller BT; Shenoy S; McClure S; Howard TK; Flye MW
    Clin Transplant; 1996 Apr; 10(2):195-8. PubMed ID: 8664518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Charcoal and isoflurane alveolar washout in low-flow circuit].
    Romano E; Pegoraro M; Vacri A; Pecchiari C; Auci E
    Minerva Anestesiol; 1993 May; 59(5):223-7. PubMed ID: 8355862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual volatile anesthetics after workstation preparation and activated charcoal filtration.
    Müller-Wirtz LM; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
    Acta Anaesthesiol Scand; 2020 Jul; 64(6):759-765. PubMed ID: 32153012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthetic emergencies in oral surgery: malignant hyperthermia, endocrinopathy, and neurologic events.
    Herlich A
    Oral Maxillofac Surg Clin North Am; 2013 Aug; 25(3):507-14, vii. PubMed ID: 23664228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant hyperthermia--a life endangering anesthesia incident during rhinological cyst surgery (author's transl)].
    Sümnig W; Freitag B
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(2):140-4. PubMed ID: 6450497
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant hyperthermia: successful management of a probable case.
    Jantzen JP; Hackett GH; Ellermeyer W; Giesecke AH
    Tex Med; 1985 Nov; 81(11):37-42. PubMed ID: 4071442
    [No Abstract]   [Full Text] [Related]  

  • 20. Response by the authors, reflection of volatile anesthetic by the vapor-clean filter.
    Müller-Wirtz LM; Meiser A; Kermad A; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
    Acta Anaesthesiol Scand; 2020 Oct; 64(9):1383-1384. PubMed ID: 32686079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.